As of 2024-12-15, the Relative Valuation of Eli Lilly and Co (LLY) is 275.51 USD. This relative valuation is based on P/E multiples. With the latest stock price at 789.12 USD, the upside of Eli Lilly and Co based on Relative Valuation is -65.1%.
The range of the Relative Valuation is 218.51 - 322.46 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.6x - 33.9x | 33.1x |
| Forward P/E multiples | 30.9x - 45.7x | 36.7x |
| Fair Price | 218.51 - 322.46 | 275.51 |
| Upside | -72.3% - -59.1% | -65.1% |
| Date | P/E |
| 2024-12-13 | 89.50 |
| 2024-12-12 | 88.73 |
| 2024-12-11 | 90.29 |
| 2024-12-10 | 90.69 |
| 2024-12-09 | 91.14 |
| 2024-12-06 | 93.77 |
| 2024-12-05 | 93.64 |
| 2024-12-04 | 94.12 |
| 2024-12-03 | 92.25 |
| 2024-12-02 | 90.71 |
| 2024-11-29 | 90.21 |
| 2024-11-27 | 89.40 |
| 2024-11-26 | 89.53 |
| 2024-11-25 | 85.63 |
| 2024-11-22 | 84.84 |
| 2024-11-21 | 85.06 |
| 2024-11-20 | 85.45 |
| 2024-11-19 | 82.77 |
| 2024-11-18 | 82.48 |
| 2024-11-15 | 84.63 |
| 2024-11-14 | 89.17 |
| 2024-11-13 | 92.08 |
| 2024-11-12 | 92.88 |
| 2024-11-11 | 94.42 |
| 2024-11-08 | 94.31 |
| 2024-11-07 | 90.45 |
| 2024-11-06 | 88.06 |
| 2024-11-05 | 91.42 |
| 2024-11-04 | 91.43 |
| 2024-11-01 | 92.88 |
| 2024-10-31 | 94.11 |
| 2024-10-30 | 96.05 |
| 2024-10-29 | 102.48 |
| 2024-10-28 | 101.58 |
| 2024-10-25 | 101.25 |
| 2024-10-24 | 101.09 |
| 2024-10-23 | 102.45 |
| 2024-10-22 | 103.12 |
| 2024-10-21 | 102.77 |
| 2024-10-18 | 104.12 |
| 2024-10-17 | 104.02 |
| 2024-10-16 | 103.94 |
| 2024-10-15 | 103.59 |
| 2024-10-14 | 105.43 |
| 2024-10-11 | 105.71 |
| 2024-10-10 | 103.29 |
| 2024-10-09 | 104.32 |
| 2024-10-08 | 103.63 |
| 2024-10-07 | 101.90 |
| 2024-10-04 | 100.62 |